Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
21.13
-0.90 (-4.09%)
Feb 21, 2025, 4:00 PM EST - Market closed
IART Revenue
Integra LifeSciences Holdings had revenue of $380.83M in the quarter ending September 30, 2024, a decrease of -0.41%. This brings the company's revenue in the last twelve months to $1.56B, up 1.45% year-over-year. In the year 2023, Integra LifeSciences Holdings had annual revenue of $1.54B, down -1.03%.
Revenue (ttm)
$1.56B
Revenue Growth
+1.45%
P/S Ratio
1.04
Revenue / Employee
$396,584
Employees
3,946
Market Cap
1.63B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.54B | -16.09M | -1.03% |
Dec 31, 2022 | 1.56B | 15.22M | 0.99% |
Dec 31, 2021 | 1.54B | 170.58M | 12.43% |
Dec 31, 2020 | 1.37B | -145.69M | -9.60% |
Dec 31, 2019 | 1.52B | 45.12M | 3.06% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
IART News
- 11 days ago - Jan De Witte joins GHO Capital as Operating Partner - GlobeNewsWire
- 18 days ago - Notice To Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf - GlobeNewsWire
- 18 days ago - Integra LifeSciences to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on February 25, 2025 - GlobeNewsWire
- 5 weeks ago - Integra LifeSciences Launches Integra Institute for Healthcare Professionals (HCPs) - GlobeNewsWire
- 3 months ago - Integra's DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research - GlobeNewsWire
- 3 months ago - Integra LifeSciences Holdings Corporation (IART) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Integra LifeSciences Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Integra LifeSciences Announces Appointment of Mojdeh Poul as President and Chief Executive Officer - GlobeNewsWire